Ticker | Value | Shares | Price | Security | Type | Insider | Title | Return | Flags | Date |
|---|---|---|---|---|---|---|---|---|---|---|
| No transactions found | ||||||||||
Dave Helsel currently holds 28,289 shares of HAEMONETICS CORP (HAE), valued at approximately $0. This represents their equity stake as Executive.
Based on SEC Form 4 filings, Dave Helsel has been a net seller of HAE stock. They have purchased $17.8K and sold $432.5K worth of shares.
Dave Helsel's most recent insider trade was on Jul 21, 2023, when they sold 365 shares at $8.65 per share.
Dave Helsel serves as Executive at HAEMONETICS CORP (HAE). They have executed 47 insider transactions totaling $450.3K over their tenure at the company.
Dave Helsel holds the position of Executive at HAEMONETICS CORP, where they are responsible for executive-level decision-making and strategic oversight. They have been associated with the company for 15 years and currently hold a stake valued at $0.
Dave Helsel has shown a selling trading pattern, with $17.8K in total purchases and $432.5K in total sales across all transactions. Their most recent activity indicates a tendency to reduce their position.
The largest transaction by Dave Helsel was on Jul 29, 2022, when they sold $112.2K worth of ANGO shares. This transaction involved 5,000 shares at $22.44 per share.
Dave Helsel currently owns 28,289 shares of HAEMONETICS CORP (HAE), with an estimated value of $0. This stake represents their equity holdings accumulated through purchases, awards, and option exercises.
All of Dave Helsel's SEC Form 4 insider trading filings are tracked on this page. Each transaction links directly to the official SEC EDGAR filing. Dave Helsel has 47 Form 4 filings on record as an insider at HAEMONETICS CORP.
Set alerts for Dave Helsel and 40,000+ other insiders.